Annual report pursuant to section 13 and 15(d)

Balance Sheets

v2.4.0.6
Balance Sheets (USD $)
Feb. 29, 2012
Feb. 28, 2011
Assets    
Cash and cash equivalents $ 511 $ 11,604
Total current assets 511 11,604
Total assets 511 11,604
Liabilities and Stockholders’ Equity (Deficiency)    
Accounts payable and accrued expenses 644 4,150
Loan payable to stockholder 491 0
Convertible notes payable 20,000 0
Total current liabilities 21,135 4,150
Stockholders’ equity (deficiency):    
Preferred stock, $0.001 par value; 10,000,000 shares authorized; none issued and outstanding 0 0
Common stock, $0.001 par value; 120,000,000 shares authorized, 48,960,000 issued and outstanding 48,960 48,960
Additional paid-in capital (27,960) (27,960)
Deficit accumulated during development stage (41,624) (13,546)
Total stockholders’ equity (deficiency) (20,624) 7,454
Total liabilities and stockholders’ equity (deficiency) $ 511 $ 11,604